Cardiology Perspective

 
 
  • Advancing Cardiovascular Health Equity Through Prevention Science This review highlights achieving optimal cardiovascular health via a coordinated multidisciplinary approach. Conscious efforts to improve community engagement and health care policy are needed to mitigate inequities and achieve social justice.
  • Medscape Nurse Career Satisfaction Report 2023 Several categories of nurses describe what makes them happiest and unhappiest with their career, how the abuse they experience shapes their views, and other facets of career satisfaction.
  • Why Are Prion Diseases on the Rise?   Remember the outbreak of "mad cow disease" in the 1990s? Creutzfeldt-Jakob is increasing again, but this time, we don't know why.
  • The Truth About Vaping   The idea that vaping is harmless is going up in smoke. What would you tell your own kids or grandkids about e-cigarette use?
  • Is Lifelong LDL-C Lowering Within Reach?   Michelle O'Donoghue interviews Verve CEO and cardiologist Sekar Kathiresan about PCSK9 gene editing to lower LDL cholesterol and the findings of the heart-1 study.
  • HDL-C Levels' Role in Cardioprotection: 5 Things to Know Targeting HDL-C function can be an effective strategy to understand mechanisms related to CV protection, which in turn can lead to the development of newer therapies to prevent CVD.
  • Dec 08 2023 This Week in Cardiology   Three aspects of the recent AF guideline documents and a possible new treatment of POTS are the topics John Mandrola, MD, discusses in this week's podcast.
  • Revamped APS Criteria and Their Impact on Clinical Research Dr Medha Barbhaiya and Dr Doruk Erkan answer questions about the new ACR-EULAR criteria and how they improve upon Sapporo APS classification criteria last updated in 2006.
  • Change Makers: Bill Meury on Transformative Medicines Bill Meury, president and CEO of Karuna Therapeutics, speaks with WebMD Chief Medical Officer John Whyte, MD, about the differences in drug development in psychiatry and the importance of innovation.
  • Axial Spondyloarthritis Highlights From ACR 2023   Key data on axial spondyloarthritis (axSpA) from ACR 2023 include efficacy of intravenous secukinumab, effect of long-term NSAID use, and referral recommendations for patients with suspected axSpA.
  • Key Updates in Obesity From AHA 2023   Highlights in obesity from AHA 2023 include an overview of the SELECT and SURMOUNT trials, cost-effectiveness of weight loss therapies, and the association of obesity with the risk for heart failure.
  • Return to Play in Athletes With Acute Myocarditis An expert analysis of the recommended protocol.
  • Medscape Female Physician Wealth & Debt Report 2023 Female physicians discuss their track record in building family net worth and reveal how they feel about their savings, spending, investing, and other aspects of personal finance.
  • Dr Christmas on Managing Menopausal Symptoms   Dr Monica Christmas's gift to The Curbsiders is expert advice on using hormonal and nonhormonal therapies in perimenopause.
  • Semaglutide Reduces Cardio Risk in Obesity Without Diabetes   Anne Peters discusses recent data on semaglutide and cardiovascular outcomes in patients with preexisting cardiovascular disease and obesity, but with no history of diabetes.
  • Are You Sure Your Patient Is Alive?   Someone knows when a person has died, but a shocking lack of sharing that news is causing problems for clinicians, families, and health systems.
  • Pig Organs in Humans: We're Not Ready Yet, Says Ethicist   Bioethicist Art Caplan discusses the current status of using of pig organs for transplantation in humans.
  • Predicting HF Worsening: Speech Analysis Beats Weighing Scales   Heart failure experts, Ileana Piña and Bill Abraham, discuss the HearO study on the use of AI for detecting congestion remotely and other tips and tricks they have learned over the years.
  • Dec 01 2023 This Week in Cardiology   More from AHA including SGLT2 inhibitors, blood transfusion after MI; cracks in the armor of Factor XI inhibitors; and renal denervation are the topics John Mandrola, MD, covers in this week’s podcast.
  • Key Updates in Diabetes From AHA 2023   Highlights in diabetes from AHA 2023 include a meta-analysis of the DAPA-HF and DELIVER trials, therapeutic effects of SGLT2 inhibitors, and the lag in uptake of this therapy in the clinical setting.